Ovarian Cancer Cells’ Dependence on Fat Suggests New Therapeutic Target
The enzyme Carnitine Palmitoyltransferase 1A (CPT1A) may control how much fat ovarian cancer cells can burn, suggesting a treatment that limits these cells’ access to CPT1A may starve them of the resources they need to spread.
COVID-19 Patients May Carry Virus after Symptoms Have Resolved
The study found that the incubation period of the virus was five days for all but one of the patients, and the average duration of symptoms was eight days. However, the length of time that patients remained contagious after resolution of their symptoms ranged from one to eight days.
Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
COVID-19 Symptom Checker for Individual Monitoring
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.
New Institute to Seek AI-Based Solutions to Curbing COVID-19 Pandemic
C3.ai DTI will focus its research on AI, machine learning, the internet of things, big data analytics, human factors, organizational behavior, ethics, and public policy.
Biomarker of Female Precancer Risk from HPV Found in Microbiome
Gardnerella bacteria were the dominant biomarker for the progression of HR-HPV and its effect is mediated by increased cervicovaginal bacterial diversity directly preceding the progression of a persistent infection to precancer.
Stanford Researchers Dig Into Community Spread of COVID-19
The researchers explain why it is an urgent matter for environmental engineers and scientists to collaborate on pinpointing viral and environmental characteristics that affect COVID-19 transmission via surfaces, the air, and fecal matter.
Sophia Genetics, Paragon Genomics Team on SARS-CoV-2 Testing
The collaboration will provide a COVID-19 test offering that combines Paragon Genomics' CleanPlex SARS-CoV-2 NGS panel reagent kit for whole-genome sequencing of the coronavirus with the advanced analytical power of the SOPHiA platform.
![ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1550-218x150.jpeg "Removing EGR4 “Brake” on Immune Activation May Be Viable I/O Therapeutic Approach")
Removing EGR4 “Brake” on Immune Activation May Be Viable I/O Therapeutic Approach
New research demonstrates that taking EGR4 away promotes the activation of killer T cells, which infiltrate and attack tumors and thereby boost anticancer immunity.
Moderna Charts Fast Track of SARS-CoV-2 Vaccine to Clinical Trials
As Moderna's vaccine development moves at unprecedented speed, the company's CEO explains how they have moved so quickly and why he is hopeful that their pace will continue.
